Wednesday, October 22, 2025

Fungi paved the way for life on land hundreds of millions of years earlier than previously thought




The study, published in Nature Ecology & Evolution, shows that early interactions between fungi and algae may have played a key role in the spread of life across the continents




Universitat Oberta de Catalunya (UOC)




After reviewing the evolutionary timeline of fungi, an international team of scientists has determined that their origin dates back to between 900 million and 1.4 billion years ago, a much earlier timeframe than previously believed. This means that fungi had already been living on Earth hundreds of millions of years before plants took root on our planet. The findings, published in open access in the journal Nature Ecology & Evolution, came thanks to the use of a new methodology and sophisticated evolutionary models combining a variety of dating techniques.

The study is the product of international collaboration between multidisciplinary researchers from various countries and institutions, including the evolutionary biologist Eduard Ocaña, Ramon y Cajal researcher at the Universitat Oberta de Catalunya (UOC).

"As a group, fungi are much older than previously imagined. It's highly likely that they were already around over a billion years ago, making them one of the oldest major groups of eukaryotes," he said. As a result, fungi (a kingdom that encompasses mushrooms, moulds and single-cell species such as yeasts) must be older than animals (which are thought to have appeared around 600 million years ago) and multicellular land plants (around 500 million years ago).

 

A new timeline for dating the origins of life

Unlike plants or animals, which have left a rich and recognizable fossil record, fungi's delicate and fibrous bodies are rarely preserved. Due to the limited number of fossils, their evolutionary history has so far been a puzzle full of missing pieces. To overcome this challenge, the researchers combined three different and complementary sources of information: the few fossils available, the genomic sequences of over a hundred species of fungi, and the effect of horizontal gene transfers, a key and innovative process that proved crucial in their endeavour.

These horizontal gene transfers are a rare but very important biological phenomenon whereby a gene crosses from one species to another. "When a gene jumps from one organism to another, that tells us that the two existed at the same time. This enables us to establish relative timelines, because any relative of the donor lineage must necessarily be older than any descendant of the lineage that received the gene," said Ocaña. By using these chronological markers from horizontal gene transfer events, together with other techniques and new computational tools that reduce calculation times, the experts were able to obtain new, more accurate and reliable evolutionary timelines for over 100 species of fungi.

 

Fungi: terrestrial ecosystem pioneers

The discovery is not just about dates. It has profound implications when it comes to our understanding of pre-Cambrian terrestrial ecosystems, as we have little information on them in terms of fossil records, especially as regards the proportions of different groups of eukaryotes. According to Ocaña, "our findings show that fungi were already present on land environments at least 800 million years ago and had ecological interactions with the ancestors of multicellular land plants, although we're currently unsure about the degree of complexity of these interactions. These ancestors probably shared similarities with the green algae groups that are evolutionarily closest to multicellular land plants, some of whose members have some degree of adaptability to non-aquatic environments."

Today's fungi form symbiotic relationships with most plants, providing nutrients in exchange for carbohydrates. These relationships, known as mycorrhizae, may date back to very ancient times: millions of years ago, early fungi may have supported algae and early plants as they adapted to living on Earth in exchange for new sources of energy. "If we accept that fungi were instrumental in helping plants colonize the Earth, our theory is that this partnership may have started much earlier than previously thought, in environments similar to biological soil crusts or the microbial mats that we still have today," said Ocaña, who works with the UOC eHealth Centre and the UOC-TECH Centre.

 

Rewriting the "empty Earth" narrative

According to the usual narrative about the origin of plants, our planet was bare and hostile until they started to take root around 500 million years ago. This new research challenges this perception: multicellular land plants appeared millions of years after their single-cell ancestors emerged and after fungi started to engage in ecological interactions on land. By breaking rocks, decomposing minerals and recycling nutrients, those early fungi helped generate the first soils, making the environment more hospitable.

Fungi were therefore involved in establishing the earliest terrestrial ecosystems, a finding that would not have been possible without the international collaboration of scientists from a very wide range of backgrounds, including evolutionary biologists, palaeontologists, fungal experts and creators of new methodological tools. "The idea originated from an innovative tool developed by Dr Gergely J. Szöllősi's Hungarian group, of which I was a member when I was doing my postdoctoral research. These findings wouldn't have been possible without this collaboration or the contributions made by researchers from Hungary, England, Japan and Catalonia."

 

New questions for the future

This discovery also paves the way for new lines of research. The authors are now considering applying the same methodology to other major groups of eukaryotes to obtain a more accurate chronology of the entire course of evolutionary history. "Fungi were a great subject of study, because the scarcity of fossil records meant that our approach provided significant added value. The next challenge is to extend these techniques to all eukaryotes to develop a much finer molecular clock for all complex life," said Ocaña.

 

Eduard Ocaña's work as a Junior Leader postdoctoral researcher, funded by "la Caixa" Foundation, has been carried out as part of the UOC's digital transition and sustainability, and digital health and planetary well-being research missions, and contributed to the UN Sustainable Development Goals (SDGs), especially 15, Life on Land.

 

Transformative, impactful research

At the UOC, we see research as a strategic tool to advance towards a future society that is more critical, responsible and nonconformist. With this vision, we conduct applied research that's interdisciplinary and linked to the most important social, technological and educational challenges.

The UOC’s over 500 researchers and more than 50 research groups are working in five research units focusing on five missions: lifelong learning; ethical and human-centred technology; digital transition and sustainability; culture for a critical society, and digital health and planetary well-being.

The university's Hubbik platform fosters knowledge transfer and entrepreneurship in the UOC community.

More information: www.uoc.edu/en/research

 

BU researcher receives Social Justice Award



Boston University School of Medicine






(Boston)—Jillian C. Shipherd, PhD, professor of psychiatry at Boston University Chobanian & Avedisian School of Medicine and an affiliate psychologist at the Women’s Health Sciences Division of the National Center for PTSD at VA Boston Healthcare System, has received a 2025 Charles Silverstein Lifetime Achievement Award in Social Justice from the Association for Behavioral and Cognitive Therapies (ABCT). The award is given to individuals who have made significant and sustained lifetime contributions to advancing social justice initiatives over many years.

Shipherd’s area of expertise is the interface of mental and physical health subsequent to trauma with a focus on sexual and gender minority populations. This award recognizes her international expertise and work in LGBTQ+ health policy, education and research, including trauma recovery.

 

She has successfully directed more than $4 million in grant funding and is the author of more than 150 peer-reviewed publications and dozens of book chapters, has served on the editorial board of LGBT Health and other journals, as well as co-editor of the book Adult Transgender Care: An Interdisciplinary Approach for Training Mental Health Professionals.

 

Shipherd has received a dozen awards for her distinguished contributions in LGBTQ+ health from leading organizations, including the American Psychological Foundation Gold Medal Award for Impact.

 

She earned her PhD in clinical psychology at the State University of NY at Buffalo and completed her pre-doctoral internship at the Boston Consortium at the VA Boston Healthcare System.

 

ABCT is an interdisciplinary organization committed to the advancement of a scientific approach to the understanding and amelioration of problems of the human condition. These aims are achieved through the investigation and application of behavioral, cognitive, prevention and treatment. The Charles Silverstein Lifetime Achievement Award in Social Justice was designed to recognize the critical, and often under-recognized, contributions from cognitive and/or behavior therapy grassroots activists who are from and primarily work with minoritized and oppressed communities.

 

US Researchers highlight ethical concerns when clinical trials are cut short



The termination of thousands of federal grants that fund clinical trials threatens to reverse substantial progress in understanding and treating the health challenges of marginalized populations, particularly children and adolescents.




Boston University School of Public Health




A new commentary in the medical journal Pediatrics raises important concerns about the ethics of stopping clinical trials before they are completed, especially when those studies involve children and teenagers.

As of July 2025, the National Institutes of Health cut about 4,700 grants connected to more than 200 ongoing clinical trials. These studies planned to involve more than 689,000 people, including roughly 20 percent who were infants, children, and adolescents. Many of these young participants were dealing with serious health challenges such as HIV, substance use, and depression, and the studies specifically focused on improving the health of people who identify as Black, Latinx, or sexual and gender minority.

The current terminations threaten to upend the progress made in the past few decades, write Amelia Knopf, associate professor at the Indiana University School of Nursing, Kathryn Macapagal, associate professor at Northwestern University Feinberg School of Medicine, and Kimberly Nelson, associate professor at Boston University School of Public Health.

In the commentary, titled “Ethical Implications of Study Terminations,” the authors examine what happens when these research studies end abruptly. They argue that such sudden closures can break trust and harm participants, especially when the research involves young people. They also note that these actions conflict with long-standing ethical principles outlined in the Belmont Report—federal guidelines published in 1979 that outline three main principles for human research: respect for persons, beneficence, and justice.

"Trust between researchers and research participants is an essential part of any study and can take a long time to develop, particularly with participants who have been historically excluded from research or marginalized in our society,” says Nelson, who studies ethical and legal issues involved in sexual health research and interventions with adolescents. “Stopping a clinical trial in the middle of data collection—not for safety or scientific reasons, but for political reasons—is a violation of that trust. It is an inherent breach of the agreement that was made between the researchers and the participants, where participants accept the risks of participating with the hope that there will be personal and societal benefits if the intervention proves to be effective."

Despite being at greater risk for many of the health conditions that clinical trials address, many of the populations participating in the abruptly canceled clinical trials are underrepresented in this research. In particular, young people who are able to participate in clinical trials often face concerns or barriers around their ability to consent and confidentiality of sensitive information that they share in these trials.

Knopf, who studies HIV prevention and bioethics in her research, says everyone should be concerned.

“In the short-term, children, adolescents, and their families are experiencing disruptions to or the termination of benefits that research participation provides,” says Knopf. “In some cases, the disruption to funding has resulted in contamination of the study design and participants have had to be withdrawn and their data will not be usable. The long-term impact may be lower trust in research, less willingness to participate, and slower scientific progress.”

The authors, all adolescent health researchers, have enrolled thousands of young participants in their clinical trials, and further explain the effects of ending these studies suddenly. First, participants are not informed that their studies might be defunded or shut down for political or funding reasons, which challenges the idea of true informed consent. Secondly, closing studies abruptly also makes it harder to know whether treatments work, reducing the value of contributions from participants who agreed to take part to advance public health.

The authors call for better ways to track the effects of study terminations on participants and stronger guidelines to ensure that research projects end in an ethical way.

Tracking the health consequences of terminated studies is more important than ever, but also more difficult, amid recent budget cuts to the federal health agencies that collect this information, as well as significant changes to the way this type of data about marginalized communities is collected and reported. The authors urge foundations and private funders to prioritize research on the health and well-being of these individuals and communities who are being erased from public record.

Importantly, as threats to scientific research continue to unfold, they also emphasize the need for researchers to develop a plan for ethical study termination that respects and honors participants’ valuable contributions towards societal good.

** 

About Boston University School of Public Health 

Founded in 1976, Boston University School of Public Health is one of the top ten ranked schools of public health in the world. It offers master's- and doctoral-level education in public health. The faculty in six departments conduct policy-changing public health research around the world, with the mission of improving the health of populations—especially the disadvantaged, underserved, and vulnerable—locally and globally.